OPKO Health, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
OPKO Health, Inc. (OPK) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$188.52 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-26
- OPKO Health, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$188.52B, a 511.64% decline from fiscal 2024.
- OPKO Health, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $45.80B.
- OPKO Health, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$198.39B.
- OPKO Health, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$389.44M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$188.52B 10-K · filed 2026-02-26 | |
| 2024-12-31 | $45.80B 10-K · filed 2026-02-26 | $45.80M 10-K · filed 2025-03-03 |
| 2023-12-31 | -$198.39B 10-K · filed 2026-02-26 | -$198.39M 10-K · filed 2024-03-01 |
| 2022-12-31 | -$389.44M 10-K · filed 2025-03-03 | |
| 2021-12-31 | -$2.96M 10-K · filed 2024-03-01 | |
| 2020-12-31 | $81.73M 10-K · filed 2023-02-27 | |
| 2019-12-31 | -$236.54M 10-K · filed 2022-03-01 | |
| 2018-12-31 | -$132.10M 10-K · filed 2021-02-18 | |
| 2017-12-31 | -$247.94M 10-K · filed 2020-03-02 | |
| 2016-12-31 | -$92.17M 10-K · filed 2019-03-01 | |
| 2015-12-31 | -$113.61M 8-K · filed 2019-01-29 | |
| 2014-12-31 | -$84.08M 10-K · filed 2017-03-01 | |
| 2013-12-31 | -$74.86M 10-K · filed 2016-02-29 | |
| 2012-12-31 | -$34.06M 10-K · filed 2015-02-27 | |
| 2011-12-31 | -$24.09M 10-K · filed 2014-03-03 | |
| 2010-12-31 | -$11.21M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |